Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 May 3.
Published in final edited form as: J Org Chem. 2019 Apr 2;84(9):5167–5175. doi: 10.1021/acs.joc.9b00145

Enantioselective Total Syntheses of (+)-Fendleridine and (+)-Acetylaspidoalbidine

Arun K Ghosh 1,*, Joshua R Born 1, Luke Kassekert 1
PMCID: PMC6594018  NIHMSID: NIHMS1029332  PMID: 30939004

Abstract

Enantioselective syntheses of hexacyclic aspidoalbidine alkaloids (+)-fendleridine (2) and (+)-acetylaspidoalbidine (3) are described. These syntheses feature an asymmetric decarboxylative allylation and photocyclization of a highly substituted enaminone. Also, the synthesis highlights the formation of the C19 hemiaminal ether via a reduction/condensation/intramolecular cyclization cascade with the C21-alcohol. The present synthesis provides convenient access to the aspidoalbidine hexacyclic alkaloid family in an efficient manner.

Graphical abstract

graphic file with name nihms-1029332-f0008.jpg

Introduction

The indoline alkaloids constitute a large family of monoterpene natural products that display immense structural diversity.1,2 The structural core of these natural products is comprised of polycyclic fused ring systems with contiguous chiral centers as represented in aspidospermidine (1, Figure 1), one of the parent members.3,4 Several Aspidosperma alkaloids exhibit a broad range of intriguing pharmacological activity, including anticancer and antibacterial among many others.5,6,7 Over the years, many strategies have been developed for their syntheses, both racemic and enantioselective manner.1,2,810 However, general strategies for the synthesis of the subset aspidoalbidine family of alkaloids received relatively less attention due to further structural complexity. As shown, (+)-fendleridine (2), also known as aspidoalbidine, and (+)-1-acetylaspidoalbidine (3), contain a unique C19 hemiaminal ether functionality in place of the C19 C-N linkage typical of aspidosperma alkaloids.11,12 Other representative oxidized forms of these natural products include (+)-haplocine (4), (+)-haplocidine (5), (+)-cimicine (6), and (−)-aspidophytine (7).13,14

Figure 1.

Figure 1.

Structures of selected aspidosperma alkaloids

Fendleridine (2) was isolated from the Venezuelan tree Aspidosperma fendleri Woodson in 1964.15 Later, it was also isolated from the Venezuelan tree species, Aspidosperma rhombeosignatum Markgraph in 1979.16 The corresponding 1-acetyl derivative, 1-acetylaspidoalbidine was first isolated from the Peruvian plant, Vallesia dichotoma Ruitz at Pav in 1963.17 Fendleridine can be viewed as a biosynthetic product of the cyclization of N-protected derivative of (+)-limaspermidine (8). A few syntheses of 1-acetylaspidoalbidine were carried out by the oxidation and cyclization of 8.1820 The first total synthesis of fendleridine (2) and 1-acetylaspidoalbidine (3) was reported by Ban and co-workers in 1975 and 1976.19,21 Overman and co-workers in 1991 also reported a formal synthesis of 1-acetylaspidoalbidine (3) in racemic form, using the aza-Cope-Mannich reaction as the key strategy.22 Subsequently, syntheses of (−)-aspidophytine (7) and haplophytine, related members of aspidoalbine family were reported.23,24 Boger and co-workers first reported total synthesis of (+)-fendleridine (2) and (+)-1-acetylaspidoalbidine (3) and unambiguously established absolute configuration of these parent members.25 They utilized a (4+2)/(3+2) cycloaddition cascade reaction that constructed the pentacyclic framework.26 Movassaghi and co-workers recently reported syntheses of these alkaloids via oxidation of the C19-iminium ion to install the C19-hemiaminal functionality.27 These two syntheses employed the use of chiral HPLC and enzymatic resolution, respectively, to separate out the sought after intermediates. In this paper, we report enantioselective synthesis of (+)-fendleridine (2) and (+)-acetylaspidoalbidine (3) in 10-and 11-steps respectively, starting from readily accessible starting materials.

Our retrosynthetic analysis of (+)-fendleridine and (+)-1-acetylaspidoalbidine is shown in Scheme 1. As depicted, an N-protected fendleridine would be obtained from the iminium ion 9. We planned to construct the C19-hemiaminal ether functionality with defined stereochemistry through the formation of a C19 imine from the C19 ketone and C10 amine followed by intramolecular alkylation at C8 forming the iminium ion structure 9. Removal of the protecting group on the C21 alcohol would construct the C19-hemiaminal ether functionality. The stereochemistry of the C19 stereocenter will be defined based upon the stereochemistry of the C12-ethylamine and the C5 alkoxyethyl group on structure 10. The elaboration of the C12 aminoethyl functionality can be achieved by alkylation of the hexahydrocarbazol-4-one 11. The alkylation reaction with appropriate electrophile will presumably ensure the desired cis-stereochemistry depicted on the substituted cyclohexanone derivative 10. We plan to construct the hexahydrocarbozolone 11 by a photocyclization of an optically active enaminone 12 (R = Bn). Such photocyclization would provide a mixture of diastereomers at the C2 and C12 carbons. Our plan for photocyclization is motivated by previous work by Gramain and co-workers who have demonstrated photocyclization of related aryl enaminone to form hexahydrocarbazolones with trans-ring junction stereochemistry.28 The synthesis of enaminone 12 in optically active form can be achieved conveniently by using an enantioselective Stoltz decarboxylative allylation reaction.29 Enaminone 13 (R = Bn) can be prepared on a multigram scale from readily available starting materials, N-benzylaniline and 1,3-cyclohexanedione.

Scheme 1.

Scheme 1.

Retrosynthesis of (+)-Fendleridine and (+)-Acetylaspidoalbidine

As shown in Scheme 2, our synthesis commenced with the formation of multigram quantity of enaminone 13 by condensation of N-benzylaniline and 1,3-cyclohexanedione in toluene in the presence of p-TSA•H2O at reflux for 40 h. Subsequently, enaminone 13 was alkylated with LDA and allylchloroformate at –78 °C to 23 °C for 18 h to afford β-keto ester 14 in 62% yield. Alkylation of the β-keto ester 14 with tert-butyl (2-iodoethoxy)dimethylsilane was carried out in DMF in the presence of Cs2CO3 at 100 °C for 32 h to furnish racemic keto ester 15 in 70% yield.30 For catalytic asymmetric allylation, we planned to utilize Pd2(dba)3 in combination with (S)-t-Bu-Phox ligand since the prior work by Stoltz and coworkers already established that (S)-t-Bu-Phox provides the best enantioselectivity for allylation of enaminones.31 Therefore, we investigated enantioselective allylation in a number of solvents by exposure of enaminone 15 to Pd2(dba)3 (5 mol%) and (S)-t-Bu-Phox ligand (12.5 mol%) at 23 °C followed by heating the reaction mixture to a specified temperature. As shown in Table 1, initial attempts to use toluene without deoxygenation resulted in only a trace amount of desired allylated product, with largely recovered starting material and dealkylated byproduct.32 Subsequently, we deoxygenated all solvents by bubbling with Argon for at least an hour prior to use. The reaction in methyl tert-butyl ether was carried out at lower temperature due to the volatility of the solvent. This condition resulted in a trace amount of allylated product 17. The reactions in THF and benzene at 70°C however resulted in excellent yields of allylated product 17. To determine enantiomeric purity, compound 17 was converted to the benzoate derivative 18. HPLC analysis of 18 using a CHIRALCEL OD-H column showed that enantioselectivity of 17 was 77% and 81% ee, respectively (please see supporting information for further details). Freshly deoxygenated toluene was tested last and was found to furnish the optically active enaminone 17 in 88% yield and 82% ee. We utilized this condition to prepare optically active 17 on a multigram scale.

Scheme 2.

Scheme 2.

Enantioselective synthesis of enaminone 17

Table 1.

Asymmetric allylation of enaminone 15

Solvent Temperature Duration Percent Yield of 17 %ee of 18
Toluenea 70°C 12 h Trace N/A
MTBE 40°C 12 h Trace N/A
THF 70°C 30 min 97% 77%
Benzene 70°C 30 min 98% 81%
Tolueneb 70°C 30 min 88% 82%
a

Solvent not degassed.

b

Reaction carried out on multigram scale.

The synthesis of hexahydrocarbazolone ring system is shown in Scheme 3. Our initial attempt to photocyclize 17 in benzene with a mercury lamp (450 W) provided inseparable mixture (1:1) of trans-diastereomic indoline derivatives 19 and 20 along with the corresponding oxidized indole byproduct 21. Gramin and co-workers reported such a photocyclization on unsubstituted enaminone to provide hexahydrocarbazolone and the corresponding oxidized indole product.28 We attempted optimization of the photocyclization to inhibit the formation of indole byproduct 21. It turns out that careful degassing of the apparatus with benzene as the solvent and shorter reaction times afforded the indolines 19 and 20 as the major products and only a trace amount of indole byproduct 21. It is important to note that photochemical trans-indoline products are quite prone to oxidation to the indole byproduct 21. Mechanistic insights into this photocyclization reaction were recently reported by Bach and coworkers.33 For our synthesis, we utilized the crude mixture of diastereomers for the next alkylation reaction immediately. The crude photocyclization product mixture was treated with KHMDS in THF at 23 °C and then cooled to 0 °C and stirred at that temperature for 10 min. Bromoacetonitrile was added and reation was stirred for 40 min at 0 °C. This provided inseparable cis-diastereomeric products 22 and 23 in 63% yield over two steps.28b

Scheme 3.

Scheme 3.

Synthesis of diastereomeric alcohols 24 and 25

Hydroboration of the mixture of nitrile derivatives with in situ formed Cy2BH in freshly distilled THF at 0 °C to 23°C for 2.5 h followed by oxidation with NaBO3•4H2O afforded 1:1 mixture of alcohols in 98% combined yield.34 The mixture was separated by silica gel chromatography to provide the alcohols 24 and 25 as pure separable compounds. The stereochemical identity of 24 and 25 was primarily determined using extensive 1H-NMR NOESY experiments (See SI for details).

To further ascertain stereochemical identity of alcohols 24 and 25, our plan was to convert to the respective spiroketal derivative, thus creating a more rigid conformation for 2D NMR analysis. As shown in Scheme 4, the alcohols 24 and 25 were converted to the corresponding tosylate derivatives 26 and 27 in 79% and 85% yields, respectively. The TBS group of tosylate 26 was then removed by exposure to TBAF in THF at 23 °C for 7.5 h. This resulted in the formation of spiroketal derivative 28 in near quantitative yield. Similarly, we have converted 27 to spiroketal derivative 29 in excellent yield. The stereochemical assignment of the diastereomeric spiroketals 28 and 29 was carried out by extensive 2D NMR studies. The results are summarized in Figure 2. The observed specific NOESY interactions between Ha-Hb and Ha-Hc for spiroketal 28 is consistent with the depicted chemistry. Similarly, the observed NOESY between Ha-Hd and Ha-He support the assigned stereochemistry of spiroketal 29 (please see supporting information for more details). Based upon these stereochemical assignments of spiroketal structures 28 and 29, we then speculated that if the assigned stereochemistry of tosylate 27 is correct, our planned formation of iminium ion 9 (R=Bn, PG=TBS) may not be feasible upon reduction of nitrile to amine from 27. Reduction of nitrile 27 was carried out by exposure to Ra-Ni 2800 in methanol under 60 psi hydrogen in a parr apparatus at 23 °C for 21 h. These conditions resulted in the formation of the corresponding ethyl amine which concomitantly cyclized to imine 30. This further corroborated our assignment of stereochemical identity.

Scheme 4.

Scheme 4.

Stereochemical studies of ketal products 28 and 29.

Figure 2.

Figure 2.

Representative NOESY correlation of compounds 28 and 29.

Tosyl derivative 26 was readily converted to (+)-fendleridine 2 as shown in Scheme 5. Tosylate 26 was subjected to Ra-Ni 2800 under hydrogen at 60 psi to afford highly polar iminium salt 31. Treatment of the crude salt 31 with TBAF at 0 °C to 23°C for 13.5 h removed the silyl group and concomitantly formed the C19-hemiaminal ether. Purification over basic alumina provided benzyl derivative 32 in 62% yield over two steps. The N-benzyl group was successfully deprotected using lithium in liquid NH3 at –78 °C for 1.5 h to furnish synthetic (+)-fendleridine 2 in 70% yield after purification by alumina using 5% ethyl acetate in hexanes as the eluent. The 1H-NMR and 13C-NMR spectra of synthetic (+)-fendleridine 2 {[α]D20 +53.7 (c, 0.2, CHCl3)} are in complete agreement with reported25,27 spectra for synthetic and natural (+)-fendleridine. We have also converted (+)-fendleridine 2 to its acetyl derivative by acetylation with acetic anhydride and pyridine in CH2Cl2 at 23°C for 1 h to provide synthetic (+)-1-acetyl-aspidoalbidine 3 {[α]D20 + 30.2 (c, 0.15, CHCl3)} in quantitative yield after purification over alumina column. The 1H-NMR and 13C-NMR spectra of synthetic (+)-1-acetyl-aspidoalbidine 3 are in complete agreement with reported25,27 spectra with rotational isomers.

Scheme 5.

Scheme 5.

Synthesis of (+)-fendleridine and (+)-1-acetylaspidoalbidine

In summary, we have developed a short and enantioselective total syntheses of (+)-fendleridine and (+)-1-acetylaspidoalibidine. The syntheses of (+)-fendleridine and (+)-1-acetylaspidoalbidine were achieved in 10-and 11-steps, respectively, from readily available starting materials. The synthesis highlights the construction of the highly substituted hexahydrocarbazolone ring system by a photochemical reaction. The synthesis also utilizes the enantioselective formation of an enaminone containing a quaternary carbon center by Stoltz decarboxylative allylation processes. The chirality on the enaminone ensures the formation of the unique C19-hemiaminal ether functionality inherent to aspidoalbine family of alkaloids. The Ra-Ni catalyzed reduction of nitrile and subsequent cascade cyclization to iminium salt leads to the C19-hemiaminal ether very efficiently. Further application of photocyclization and synthesis of pharmacologically important indoline alkaloids are underway.

Experimental Section

General Procedural/Analytical Methods.

All reactions were done in oven-dried round-bottom flasks followed by flame-drying in the case of moisture sensitive reactions. The flasks were fitted with rubber septa and kept under a positive pressure of Argon. Cannula were used in the transfer of moisture sensitive liquids. Heated reactions were ran using an oil bath on a hot plate equipped with a temperature probe. Hydrogenations were carried out using a Parr™ shaking apparatus inside a thick-walled non-reactant borosilicate glass vessel. Photochemical transformations were done using a Hanovia 450 W Hg Lamp. TLC analysis was conducted using glass-backed thin-layer silica gel chromatography plates (60 Å, 250 μm thickness, F-254 indicator), or with glass-backed thin-layer Alumina N chromatography plates (250 μm thickness, UV 254). Flash chromatography was done using 230–400 mesh, 60 Å pore diameter silica gel, or with 80–200 mesh Alumina. Organic solutions were concentrated at 30–35 °C on rotary evaporators capable of achieving a minimum pressure of ~30 torr, and further concentrated on a Hi-vacuum pump capable of achieving a minimum pressure of ~4 torr. 1H NMR spectra were recorded on 400, 500 and 800 MHz spectrometers. 13CNMR spectra were recorded at 100, 125, and 200 MHz on the respective NMRs. Chemical shifts are reported in parts per million and are referenced to the deuterated residual solvent peak (CDCl3, 7.26 ppm for 1H and 77.16 ppm for 13C). NMR data is reported as δ value (chemical shift, J-value (Hz), integration, where s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, p = quintet, m = multiplet, dd = doublet doublets, and so on. Optical rotations were recorded on a digital polarimeter. LRMS spectra was obtained using a quadrupole LCMS under ESI+. HRMS spectra were recorded at the Purdue University Department of Chemistry Mass Spectrometry Center. These experiments were performed under ESI+ and APCI+ conditions using an Orbitrap XL Instrument.

3-(benzyl(phenyl)amino)cyclohex-2-en-1-one (13).28c,35

To a 500 mL one-neck round bottom flask equipped with a stir bar and 1,3-dicyclohexadiene (15 g, 133.8 mmol, 1.0 equiv), N-benzylaniline (26.97 g, 147.2 mmol, 1.1 equiv), and p-toluenesulfonic acid monohydrate (4.07 g, 21.4 mmol, 0.16 equiv) were added sequentially. A Dean-Stark apparatus with a reflux condenser was then attached and the entire vessel evacuated and flushed with Argon several times. Toluene (267 mL) was added and the reaction heated at 160 °C for 40 h. After this period, the reaction was cooled, diluted with EtOAc, washed with 1 M NaOH, brine, dried over Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 100% EtOAc as the eluent. Enaminone 13 was obtained as brown oil (34.57 g, 93%) TLC: Silica Gel (100% EtOAc), Rf = 0.31. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.15 (m, 8H), 7.11 (d, J = 7.1 Hz, 2H), 5.36 (s, 1H), 4.80 (s, 2H), 2.28 (dd, J = 14.2, 6.4 Hz, 4H), 1.88 (p, J = 6.4 Hz, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 197.6, 164.9, 144.4, 136.3, 129.6, 128.6, 127.7, 127.5, 127.4, 126.8, 101.6, 56.6, 36.1, 28.6, 22.5; LRMS-ESI (+) m/z 278.1 [M + H]+.

Allyl 4-(benzyl(phenyl)amino)-2-oxocyclohex-3-ene-1-carboxylate ((±)-14).

To a flame-dried 1L round bottom flask under Argon, diisopropylamine (34.1 mL, 243 mmol, 2.5 equiv) in freshly distilled THF (144 mL) was added. To this solution at 0 °C, n-BuLi (1.6 M in hexanes, 152 mL, 243 mmol, 2.5 equiv) was added and the reaction was stirred for 50 min. In a separate flame-dried 1 L flask enaminone 13 (27 g, 97.2 mmol, 1 equiv) was dissolved in THF (125 mL) and the solution was cannulated to the yellow solution of above LDA at –78 °C. The resulting mixture was stirred at –78°C for 1 h then allyl chloroformate (13.4 mL, 126.4 mmol, 1.3 equiv) was added dropwise. The resulting reaction was allowed to warm slowly to 23 °C for 12 h. The reaction was quenched with saturated NH4Cl (250 mL), extracted with EtOAc (3x), washed with brine, dried over Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel to provide product as a viscous dark red oil (21.8 g, 62% yield), and unreacted starting material (4.9 g) was recovered (76% yield, brsm). TLC: Silica Gel (50% EtOAc:Hexanes), Rf = 0.34. 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.20 (m, 6H), 7.17 (d, J = 7.0 Hz, 2H), 7.11 (d, J = 7.0 Hz, 2H), 5.90 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H), 5.39 (s, 1H), 5.31 (dq, J = 17.2, 1.5 Hz, 1H), 5.19 (dq, J = 10.4, 1.2 Hz, 1H), 4.82 (s, 2H), 4.69 – 4.58 (m, 2H), 3.32 (dd, J = 8.7, 5.0 Hz, 1H), 2.57 – 2.46 (m, 1H), 2.36 – 2.23 (m, 2H), 2.17 – 2.06 (m, 1H); 13C{1H} NMR (101 MHz, CDCl3) δ 191.0, 170.7, 164.6, 144.0, 136.0, 132.0, 129.7, 128.7, 127.8, 127.7, 127.5, 126.9, 118.1, 100.5, 65.5, 56.7, 51.5, 26.6, 25.2; HRMS-ESI (+) m/z calcd for C23H23NO3 [M + H]+: 362.1751, found 362.1755.

Allyl 4-(benzyl(phenyl)amino)-1-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-oxocyclohex-3-ene-1-carboxylate ((±)-15).

To a flame-dried 1L round bottom flask under Argon equipped with a stir bar and reflux condenser, racemic 14 (21.8 g, 60.2 mmol, 1 equiv) in DMF (500 mL) was added. To this solution, tert-butyl(2-iodoethoxy)dimethylsilane (33.4 mL, 150.4 mmol, 2.5 equiv) followed by Cs2CO3 (39.2 g, 120.4 mmol, 2.0 equiv) was added. The resulting reaction was heated in an oil bath to 100 °C for 32 h. After this period, the reaction was quenched with H2O and brine (100 mL each). The resulting mixture was extracted with CH2Cl2, washed with 5% aqueous LiCl solution. The crude mixture was concentrated and purified via column chromatography over silica gel using 25 – 55% EtOAc/Hexanes as the eluent to yield allyl carbonate 15, (21.9 g, 70.1% yield) as an orange amorphous solid. Unreacted starting material was recovered (3.2 g, 82 % yield, brsm). TLC: Silica Gel (25% EtOAc:Hexanes), Rf = 0.2. 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H), 7.25 (d, J = 7.0 Hz, 1H), 7.18 (d, J = 6.7 Hz, 2H), 7.10 (d, J = 6.8 Hz, 2H), 5.89 (ddt, J = 17.2, 10.7, 5.5 Hz, 1H), 5.36 (s, 1H), 5.29 (dq, J = 16.8, 1.4 Hz, 1H), 5.19 (dq, J = 10.5, 1.4 Hz, 1H), 4.81 (s, 2H), 4.61 (dtdd, J = 14.9, 13.4, 5.0, 1.5 Hz, 2H), 3.72 (t, J = 6.6 Hz, 2H), 2.60 – 2.26 (m, 4H), 1.98 (dq, J = 14.0, 7.4, 6.6 Hz, 2H), 0.85 (s, 9H), 0.02 (d, J = 2.7 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 193.5, 172.2, 163.9, 144.2, 136.3, 132.2, 129.8, 128.8, 127.9, 127.8, 127.6, 127.0, 118.0, 100.3, 65.5, 60.2, 56.7, 54.4, 36.5, 29.6, 26.0, 25.9, 18.3, −5.3; HRMS-ESI (+) m/z calcd for C31H42NO4Si [M + H]+: 520.2878, found 520.2874.

(S)-6-allyl-3-(benzyl(phenyl)amino)-6-(2-((tert-butyldimethylsilyl)oxy)ethyl)cyclohex-2-en-1-one (17).

To a flame-dried round bottom flask under Argon equipped with a stir bar and reflux condenser, (S)-tBu-Phox (429.6 mg, 1.11 mmol, 12.5 mol%) and Pd2(dba)3 (406 mg, 0.44 mmol, 5 mol %) were added. Deoxygenated toluene (61 mL) was added and the resulting mixture was stirred at 23 °C for 30 min. A solution of allyl carbonate 15 (4.61 g, 8.87 mmol, 1 equiv) in toluene (61 mL) was then slowly cannulated to the orange solution containing the catalyst at 23 °C. The resulting reaction mixture was heated to 70 °C for 35 min. After this period, the orange reaction mixture was cooled and then filtered over Celite®. The filter cake was washed with CH2Cl2. The solvent was concentrated and the residue was purified via column chromatography over silica gel using 15 – 20% EtOAc:Hexanes as the eluent to provide product allylated product 17 (3.69 g, 88% yield) as viscous brown oil. TLC: Silica Gel (15% EtOAc:Hexanes), Rf = 0.16. [α]D20 −2.9 (c 0.068, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 7.24 (ml, 1H), 7.19 (d, J = 7.2 Hz, 2H), 7.12 (d, J = 7.1 Hz, 2H), 5.82 – 5.70 (m, 1H), 5.29 (s, 1H), 5.04 (s, 1H), 5.02 (d, J = 4.3 Hz, 1H), 4.82 (s, 2H), 3.72 (ddd, J = 10.1, 8.5, 6.2 Hz, 1H), 3.63 (ddd, J = 10.3, 8.7, 5.7 Hz, 1H), 2.42 (m, 2H), 2.30 (dt, J = 17.5, 5.7 Hz, 1H), 2.21 (dd, J = 13.9, 8.0 Hz, 1H), 1.87 – 1.78 (m, 3H), 1.75 – 1.69 (m, 1H), 0.87 (s, 9H), 0.03 (s, 6H); 13C{1H} NMR (126 MHz, CDCl3) δ 200.5, 163.2, 144.5, 136.7, 135.2, 129.8, 128.8, 128.0, 127.59, 127.55, 127.1, 117.6, 100.9, 59.9, 56.7, 44.5, 40.3, 37.9, 31.0, 26.1, 25.5, 18.4, −5.1, −5.2; HRMS-ESI (+) m/z calcd for C30H42NO2Si [M + H]+: 476.2979, found 476.2969.

(S)-2-(1-allyl-4-(benzyl(phenyl)amino)-2-oxocyclohex-3-en-1-yl)ethyl benzoate (18).

To a flame-dried round bottom flask under argon equipped with a stir bar allyl derivative 17 (21 mg, 0.04 mmol, 1.0 equiv) in freshly distilled THF (0.5 mL, 0.1 M) was added. To this solution, TBAF (1.0 M in THF, 46 μL, 0.05 mmol, 1.05 equiv) was added dropwise at 0 °C and the resulting mixture was stirred at 0 °C to 23 °C for 12 h. Reaction was then quenched with H2O and brine (~0.5 mL each), extracted with EtOAc (3x), washed brine, dried Na2SO4, and concentrated. The crude mixture was purified via silica gel column chromatography, using 65% EtOAc:Hexanes as the eluent to provide the corresponding alcohol as an amorphous solid (16 mg, 100% yield). TLC: Silica (65% EtOAc:Hexanes), Rf = 0.50 (UV and PMA). 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.19 (m, 6H), 7.19 (m, 2H), 7.13 (m, 2H), 5.72 (m, 1H), 5.34 (s, 1H), 5.09 (m, 1H), 5.06 (m, 1H), 4.84 (s, 2H), 3.86 (bs, 1H), 3.81 (ddd, J = 12.1, 8.2, 4.4 Hz, 1H), 3.64 (dt, J = 10.7, 4.9 Hz, 1H), 2.46 – 2.29 (m, 4H), 1.84 – 1.67 (m, 4H). 13C{1H} NMR (101 MHz, CDCl3) δ 202.6, 164.4, 144.2, 136.3, 134.2, 129.9, 128.9, 127.9 (2C), 127.7, 127.1, 118.4, 100.5, 58.9, 56.9, 45.0, 38.9, 37.9, 32.0, 25.4. LRMS-ESI (+) m/z 362.1[M + H]+.

To a flame-dried round bottom flask under Argon, equipped with a stir bar, above alcohol (15 mg, 41 μmol, 1.0 equiv) in CH2Cl2 (0.5 mL) was added. To this solution at 0 °C, DMAP (1.0 mg, 8 μmol, 0.2 equiv), triethylamine (8.4 mg, 12 μL, 0.08 mmol, 2.0 equiv), and benzoyl chloride (7 mg, 6 μL, 0.05 mmol, 1.2 equiv) were added. The resulting reaction mixture was stirred at 0 °C to 23 °C for 2.5 h. Reaction was then quenched with H2O and brine (~0.5 mL each), extracted with CH2Cl2 (3x), washed brine, dried Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel to provide benzoate 18 (18.5 mg, 96% yield) as an oil. TLC: Silica (30% EtOAc:Hexanes), Rf = 0.32 (UV and PMA) 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.1 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.41 (t, J = 7.7 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.31 – 7.22 (m, 4H), 7.18 (d, J = 6.8 Hz, 2H), 7.12 (d, J = 7.6 Hz, 2H), 5.85 – 5.75 (m, 1H), 5.34 (s, 1H), 5.09 (s, 1H), 5.06 (d, J = 4.4 Hz, 1H), 4.81 (s, 2H), 4.44 – 4.34 (m, 2H), 2.48 – 2.28 (m, 4H), 2.23 – 2.16 (m, 1H), 1.93 – 1.85 (m, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 199.78, 166.71, 163.20, 144.34, 136.49, 134.45, 132.92, 130.51, 129.82, 129.69, 128.86, 128.44, 127.97, 127.70, 127.60, 127.02, 118.25, 100.73, 62.13, 56.71, 44.42, 40.41, 33.79, 30.44, 25.32. LRMS-ESI (+) m/z 466.2 [M + H]+.

2-((3S)-3-allyl-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-oxo-1,2,3,4,9,9a-hexahydro-4aH-carbazol-4a-yl)acetonitrile (22 and 23).

To a flame-dried round bottom flask under Argon fitted with a reflux condenser and stir bar, allylated 17 (1.55 g, 3.26 mmol, 1.0 equiv) was added. Deoxygenated Benzene (163 mL) was added and the resulting mixture was flushed under Argon multiple times. Photocyclization reaction then was carried out with a 450 W Hg lamp for 1.5 h. After this period, the reaction was concentrated under reduced pressure in the dark. The resulting crude product was immediately subjected to next step.

To the above mixture, freshly-distilled THF (21.7 mL), and KHMDS (0.7 M in toluene, 5.12 mL, 3.58 mmol, 1.1 equiv) were added sequentially at 23 °C (solution went from orange gold to dark brown). The reaction cooled to 0 °C and after 10 min, BrCH2CN (238 μL, 3.42 mmol, 1.05 equiv) was added dropwise. The resulting mixture was stirred for 40 min at 0 °C. After this period, the reaction was quenched with saturated NH4Cl (15 mL). Reaction extracted with EtOAc (3x), the combined extracts were washed brine, dried with Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 5% EtOAc:Hexanes as the eluent to provide: 22 and 23 as an inseparable mixture as an oil (1.05 g, 63% over two steps). TLC: Silica Gel (15% EtOAc:Hexanes), Rf = 0.44. 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H), 7.13 (t, J = 7.0 Hz, 1H), 6.93 (d, J = 7.6 Hz, 1H), 6.66 (t, J = 8.7 Hz, 1H), 6.49 (d, J = 7.9 Hz, 1H), 5.76 (m, 0.5H), 5.54 (m, 0.5H), 5.08 (m, 1H), 5.00 (d, J = 10.1 Hz, 0.5H), 4.87 (d, J = 17.0 Hz, 0.5H), 4.53 (d, J = 12.4 Hz, 1H), 4.32 (d, J = 12.4 Hz, 1H), 3.95 (m, 1H), 3.68 (t, J = 7.1 Hz, 1H), 3.50 – 3.45 (m, 0.5H), 3.42 – 3.38 (m, 0.5H) 3.07 (d, J = 10.4 Hz, 1H), 2.59 – 2.52 (m, 1.5H), 2.28 (dd, J = 11.1, 6.38, Hz, 0.5H), 2.09 – 2.05 (m, 0.5H), 2.02 – 1.96 (m, 1H), 1.91 – 1.45 (m, 5.5H), 0.89 (s, 5H), 0.83 (s, 4H), 0.06 (d, J = 4.1 Hz, 3H), −0.04 (d, J = 9.4 Hz, 3H). 13C{1H} NMR (126 MHz, CDCl3) δ 210.9, 210.5, 150.1, 149.9, 137.7, 137.7, 133.9, 132.6, 130.5, 130.4, 128.9, 127.7, 127.5, 127.03, 126.97, 124.0, 123.8, 118.9, 118.8, 118.5, 118.3, 117.69, 117.67, 107.7, 68.99, 68.97, 59.6, 59.0, 58.2, 57.9, 49.7, 49.6, 49.5, 43.2, 41.0, 40.3, 39.3, 31.7, 27.2, 26.7, 26.6, 26.1, 26.0, 25.4, 22.8, 22.3, 22.2, 18.4, 18.3, 14.2, −5.2, −5.3; HRMS-ESI (+) m/z calcd for C32H43N2O2Si [M + H]+: 515.3088, found 515.3095.

2-((3S)-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3-(3-hydroxypropyl)-4-oxo-1,2,3,4,9,9a-hexahydro-4aH-carbazol-4a-yl)acetonitrile (24 and 25).

To a flame-dried round bottom flask under Argon equipped with a stir bar cyclohexene (1.4 mL, 13.9 mmol, 6.5 equiv) was added to freshly distilled THF (6 mL) was added at 0°C. To this solution at 0 °C, borane dimethyl sulfide complex (neat, 607 μL, 6.4 mmol, 3.0 equiv) added dropwise. A thick white slurry started to form after 1 min. Additional amounts of THF (1 mL) was added and the reaction was continued to stir at 0 °C for 1 h. After this period, a solution of 22 and 23 (1.10 g, 2.1 mmol, 1.0 equiv), in THF (5 mL) was cannulated in at 0 °C and the resulting reaction was warmed slowly to 23 °C for 2.5 h. The reaction was quenched with slow addition of NaBO3•4H20 (3.3 g, 21.3 mmol, 10 equiv) and H2O (7 mL, 0.3M), and the resulting reaction mixture was continued to stir for 12 h. The reaction was diluted in brine, extracted with EtOAc (3x), dried with Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 40% EtOAc:Hexanes as the eluent to provide alcohol diastereomers 24 and 25 (1.12 g, 98% combined yield) which were separated. TLC: Silica Gel (40% EtOAc:Hexanes), Rf = 0.52 and 0.38 (lower spot desired diastereomer).

2-((3S,4aS,9aS)-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3-(3-hydroxypropyl)-4-oxo-1,2,3,4,9,9a-hexahydro-4aH-carbazol-4a-yl)acetonitrile (25).

1H NMR (500 MHz, CDCl3) δ 7.39 – 7.28 (m, 5H), 7.12 (td, J = 7.7, 1.3 Hz, 1H), 6.90 (dd, J = 7.5, 1.2 Hz, 1H), 6.64 (td, J = 7.5, 1.0 Hz, 1H), 6.49 (d, J = 7.8 Hz, 1H), 4.53 (d, J = 15.5 Hz, 1H), 4.31 (d, J = 15.5 Hz, 1H), 3.95 (dd, J = 7.1, 4.3 Hz, 1H), 3.65 (m, 2H), 3.35 (m, 2H), 3.04 (d, J = 16.4 Hz, 1H), 2.56 (d, J = 16.4 Hz, 1H), 2.04 (m, 1H), 1.88 – 1.65 (m, 5H), 1.44 – 1.35 (m, 1H), 1.34 – 1.29 (m, 2H), 1.25 (m, 1H), 0.88 (s, 9H), 0.05 (d, J = 3.9 Hz, 6H); 13C{1H} NMR (126 MHz, CDCl3) δ 210.6, 150.0, 137.6, 130.6, 129.0, 127.8, 127.6, 127.1, 123.6, 118.1, 117.8, 107.9, 69.1, 62.9, 59.6, 58.0, 49.6, 49.4, 38.7, 35.0, 28.4, 26.9, 26.7, 26.1, 22.5, 18.4, −5.2; LRMS-ESI (+) m/z 533.3 [M + H]+.

2-((3S,4aR,9aR)-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3-(3-hydroxypropyl)-4-oxo-1,2,3,4,9,9a-hexahydro-4aH-carbazol-4a-yl)acetonitrile (24).

[α]D20 −144 (c 0.08, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.28 (m, 5H), 7.12 (td, J = 7.7, 1.3 Hz, 1H), 6.91 (dd, J = 7.5, 1.2 Hz, 1H), 6.66 (td, J = 7.5, 0.9 Hz, 1H), 6.48 (d, J = 7.9 Hz, 1H), 4.52 (d, J = 15.4 Hz, 1H), 4.30 (d, J = 15.4 Hz, 1H), 3.93 (m, 1H), 3.62 (m, 2H), 3.47 (m, 1H), 3.39 (m, 1H), 3.08 (d, J = 16.3 Hz, 1H), 2.52 (d, J = 16.3 Hz, 1H), 1.87 – 1.76 (m, 4H), 1.69 – 1.59 (m, 3H), 1.55 (m, 1H), 1.51 – 1.40 (m, 2H), 0.81 (s, 9H), −0.06 (d, J = 9.4 Hz, 6H); 13C{1H} NMR (126 MHz, CDCl3) δ 211.4, 149.8, 137.7, 130.4, 129.0, 127.8, 127.5, 127.3, 123.8, 118.6, 117.9, 107.9, 69.0, 63.3, 59.0, 58.1, 49.6, 49.4, 40.3, 32.5, 27.6, 27.3, 26.6, 26.0, 22.1, 18.3, −5.3; HRMS-ESI (+) m/z calcd for C32H44N2O3SiNa [M + Na]+: 555.3013, found 555.3009.

3-((3S,4aR,9aR)-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4a-(cyanomethyl)-4-oxo-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl)propyl 4-methylbenzenesulfonate (26).

To a flame-dried round bottom under Argon flask equipped with a stir bar, TsCl (50.1 mg, 0.26 mmol, 2.0 equiv) and DMAP (1.6 mg, 0.01 mmol, 10 mol %) in 0.3 mL CH2Cl2were added at 0°C. To this solution, alcohol 24 (70 mg, 0.13 mmol, 1.0 equiv) in CH2Cl2 (0.3 mL), followed by triethylamine addition (20.1 μL, 0.14 mmol, 1.1 equiv) was added. Additional amounts of TsCl and trimethylamine (0.5 and 0.4 equiv, respectively) were further added. The resulting reaction was warmed to 23 °C, quenched with saturated NaHCO3, (5 mL) extracted with CH2Cl2 (3x), washed with brine, dried Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 10 – 15% EtOAc:Hexanes as the eluent to provide tosylate 26 as an oil (71.4 mg, 79% yield). TLC: Silica Gel (20% EtOAc:Hexanes), Rf = 0.31. [α]D20 −101.20 (c 0.171, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.3 Hz, 2H), 7.39 – 7.28 (m, 7H), 7.12 (td, J = 7.7, 1.3 Hz, 1H), 6.87 (dd, J = 7.5, 1.2 Hz, 1H), 6.65 (td, J = 7.5, 1.0 Hz, 1H), 6.47 (d, J = 7.9 Hz, 1H), 4.51 (d, J = 15.4 Hz, 1H), 4.28 (d, J = 15.4 Hz, 1H), 4.00 (m, 2H), 3.89 (dd, J = 7.4, 4.5 Hz, 1H), 3.46 – 3.40 (m, 1H), 3.38 – 3.31 (m, 2H), 3.03 (d, J = 16.3 Hz, 1H), 2.48 (d, J = 16.3 Hz, 1H), 2.44 (s, 3H), 1.84 – 1.77 (m, 2H), 1.77 – 1.65 (m, 3H), 1.58 – 1.47 (m, 4H), 1.40 (ddd, J = 14.0, 8.3, 5.7 Hz, 1H), 0.80 (s, 9H), −0.07 (d, J = 9.0 Hz, 6H); 13C{1H} NMR (126 MHz, CDCl3) δ 210.9, 149.6, 144.9, 137.6, 133.1, 130.5, 130.0, 129.0, 128.1, 127.8, 127.5, 127.2, 123.7, 118.6, 117.8, 107.9, 71.0, 68.9, 58.8, 58.1, 49.5, 49.3, 40.0, 32.3, 27.3, 26.4, 26.0, 24.0, 22.0, 21.8, 18.3, −5.3; HRMS-ESI (+) m/z calcd for C39H51N2O5SSi [M + H]+: 687.3283, found 687.3276.

3-((3S,4aS,9aS)-9-benzyl-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4a-(cyanomethyl)-4-oxo-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl)propyl 4-methylbenzenesulfonate (27).

Same experimental as in the transformation of 24 to 26. The crude mixture was isolated via column chromatography over silica gel using 15–20% EtOAc:Hexanes as the eluent to provide tosylate 27 as yellow oil (463.2 mg, 85% yield). TLC: Silica (20% EtOAc:Hexanes), Rf = 0.29. 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.3 Hz, 2H), 7.40 – 7.28 (m, 7H), 7.11 (td, J = 7.7, 1.3 Hz, 1H), 6.80 (dd, J = 7.6, 1.3 Hz, 1H), 6.58 (td, J = 7.4, 0.9 Hz, 1H), 6.49 (d, J = 7.9 Hz, 1H), 4.52 (d, J = 15.5 Hz, 1H), 4.30 (d, J = 15.5 Hz, 1H), 3.97 – 3.87 (m, 1H), 3.76 (m, 1H), 3.67 (m, 1H), 3.59 (td, J = 6.8, 1.5 Hz, 2H), 3.00 (d, J = 16.3 Hz, 1H), 2.53 (d, J = 16.4 Hz, 1H), 2.45 (s, 3H), 1.95 (m, 1H), 1.84 – 1.65 (m, 4H), 1.61 (m, 1H), 1.54 – 1.44 (m, 1H), 1.44 – 1.32 (m, 1H), 1.27 (td, J = 12.7, 4.5 Hz, 2H), 1.09 (td, J = 13.1, 3.4 Hz, 1H), 0.86 (s, 9H), 0.02 (d, J = 2.6 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 210.4, 150.1, 144.8, 137.6, 133.1, 130.7, 129.9, 129.0, 128.0, 127.8, 127.6, 126.8, 123.4, 118.3, 117.7, 107.9, 70.4, 69.0, 59.5, 58.0, 49.7, 49.1, 38.4, 34.7, 28.3, 26.7, 26.1, 23.4, 22.5, 21.8, 18.4, −5.2; LRMS-ESI (+) m/z 687.3 [M + H]+.

2-((4aS,6aR,11bR,11cS)-7-benzyl-3,4,5,6,6a,7-hexahydro-2H,11bH−11c,4a-(epoxyethano)pyrano[3,2-c]carbazol-11b-yl)acetonitrile (28).

To a flame-dried round bottom flask under Argon equipped with a stir bar, tosylate 26 (27 mg, 39 μmol, 1.0 equiv) was dissolved in freshly distilled THF (0.4 mL, 0.1 M). To this solution at 23 °C, TBAF (1.0 M in THF, 47 μL, 47μmol, 1.2 equiv) was added dropwise and the reaction mixture was stirred for 12 h. Reaction was then quenched with H2O and brine (~0.5 mL each), extracted with EtOAc (3x), washed brine, dried Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 15% EtOAc:Hexanes as the eluent to provide tosylate 28 (15.7 mg, 99% yield) as a white amorphous solid. TLC: Silica (20% EtOAc:Hexanes), Rf = 0.34. [α]D20 +45.13 (c 0..203, CHCl3); 1H NMR (400 MHz, Chloroform-d) δ 7.34 – 7.24 (m, 6H), 7.07 (td, J = 7.7, 1.3 Hz, 1H), 6.62 (td, J = 7.4, 1.0 Hz, 1H), 6.34 (d, J = 8.3 Hz, 1H), 4.45 (d, J = 16.0 Hz, 1H), 4.35 (d, J = 16.0 Hz, 1H), 4.09 (ddd, J = 10.8, 8.4, 6.2 Hz, 1H), 3.91 (td, J = 8.6, 1.1 Hz, 1H), 3.77 (m, 2H), 3.68 (m, 1H), 2.95 (d, J = 16.6 Hz, 1H), 2.80 (d, J = 16.6 Hz, 1H), 2.02 (tt, J = 13.6, 3.5 Hz, 1H), 1.81 – 1.58 (m, 6H), 1.54 – 1.36 (m, 3H); 13C{1H} NMR (101 MHz, Chloroform-d) δ 152.1, 138.9, 129.9, 129.5, 128.7, 127.4, 127.2, 125.9, 119.3, 117.2, 108.8, 105.9, 68.3, 67.3, 61.3, 54.9, 50.9, 41.4, 38.6, 36.5, 31.3, 28.0, 24.9, 21.3; HRMS-APCI (+) m/z calcd for C26H29N2O2 [M + H]+: 401.2223, found 401.2220.

2-((4aS,6aS,11bS,11cS)-7-benzyl-3,4,5,6,6a,7-hexahydro-2H,11bH−11c,4a-(epoxyethano)pyrano[3,2-c]carbazol-11b-yl)acetonitrile (29).

To a flame-dried round bottom flask under Argon equipped with a stir bar, compound 27 (30 mg, 44 μmol, 1.0 equiv) in freshly distilled THF (0.44 mL, 0.1 M) was added. To this solution at 23 °C, TBAF (1.0 M in THF, 52 μL, 52 μmol, 1.2 equiv) was added and the resulting reaction was stirred for 12 h. Reaction was then quenched with H2O (0.5 mL), extracted with EtOAc (3x), washed brine, dried Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 20% EtOAc:Hexanes as the eluent to provide product 29 (17.5 mg, quantitative yield) as amorphous white solid. TLC: Silica (20% EtOAc:Hexanes), Rf = 0.30. [α]D20 −68.82 (c 0.364, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.53 (dd, J = 7.5, 1.3 Hz, 1H), 7.37 – 7.30 (m, 4H), 7.26 (m, 1H), 7.05 (td, J = 7.7, 1.4 Hz, 1H), 6.58 (td, J = 7.5, 1.0 Hz, 1H), 6.30 (dd, J = 7.9, 0.9 Hz, 1H), 4.47 (d, J = 15.9 Hz, 1H), 4.39 (d, J = 15.9 Hz, 1H), 4.17 (ddd, J = 10.6, 8.7, 4.9 Hz, 1H), 3.98 (ddd, J = 12.0, 9.8, 1.9 Hz, 1H), 3.93 (ddd, J = 9.6, 8.6, 7.5 Hz, 1H), 3.75 (ddd, J = 12.3, 10.4, 6.9 Hz, 1H), 3.66 (d, J = 3.7 Hz, 1H), 2.98 (d, J = 16.6 Hz, 1H), 2.93 (d, J = 16.5 Hz, 1H), 2.51 (ddd, J = 13.5, 10.6, 7.5 Hz, 1H), 1.99 – 1.89 (m, 1H), 1.83 (ddd, J = 14.0, 9.6, 4.9 Hz, 1H), 1.73 – 1.63 (m, 2H), 1.58 – 1.45 (m, 3H), 1.38 – 1.34 (m, 1H), 1.23 – 1.15 (m, 1H); 13C{1H} NMR (126 MHz, CDCl3) δ 152.4, 138.9, 129.4, 128.7, 128.4, 127.5, 127.2, 126.5, 119.2, 116.7, 109.4, 105.2, 67.8, 67.0, 58.6, 53.1, 50.4, 43.3, 38.2, 35.1, 28.4, 27.8, 23.8, 19.0; HRMS-APCI (+) m/z calcd for C26H29N2O2 [M + H]+: 401.2223, found 401.2219.

3-((4S,6aS,11bS)-7-benzyl-4-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2,4,5,6,6a,7-hexahydro-1H-pyrrolo[2,3-d]carbazol-4-yl)propyl 4-methylbenzenesulfonate (30).

To a Parr Reactor vessel under argon was added 2800 Ra-Ni (1.21 g, 300 wt %). A solution of tosylate 27 (403 mg, 0.59 mmol, 1.0 equiv) in MeOH (22 mL, 27 mM) was then cannulated in. The mixture was shaken in a Parr™ apparatus under hydrogen at 60 Psi pressure for 46 h. After this period, the resulting white solution mixture was filtered through Celite® and filter-cake was washed with MeOH and CH2Cl2 (15 mL each). Solvents were evaporated to yield imine 30 (359.5 mg, 90.8% yield). TLC: Silica (30% EtOAc:Hexanes), Rf = 0.46. 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 8.3 Hz, 2H), 7.36 – 7.27 (m, 7H), 7.03 (td, J = 7.7, 1.3 Hz, 1H), 6.63 (dd, J = 7.3, 1.2 Hz, 1H), 6.48 (t, J = 5.9 Hz, 1H), 6.40 (d, J = 7.9 Hz, 1H), 4.48 (d, J = 15.5 Hz, 1H), 4.24 (d, J = 15.5 Hz, 1H), 3.91 (dd, J = 15.4, 8.5 Hz, 1H), 3.80 (m, 1H), 3.74 (m, 1H), 3.68 (m, 1H), 3.62 (td, J = 7.2, 3.0 Hz, 2H), 3.47 (t, J = 5.7 Hz, 1H), 2.45 (s, 3H), 2.19 (dt, J = 12.2, 6.6 Hz, 1H), 1.91 (m, 1H), 1.80 (dt, J = 13.9, 6.7 Hz, 1H), 1.69 (m, 2H), 1.57 (m, 2H), 1.46 (m, 2H), 1.16 (td, J = 13.0, 5.3 Hz, 1H), 1.04 (td, J = 13.1, 3.2 Hz, 1H), 0.85 (s, 9H), 0.01 (d, J = 1.9 Hz, 7H); 13C{1H} NMR (126 MHz, CDCl3) δ 180.8, 149.2, 144.5, 138.4, 133.2, 132.4, 129.8, 128.7, 128.7, 127.9, 127.4, 127.3, 122.0, 117.4, 107.2, 71.6, 71.0, 61.0, 59.4, 56.9, 49.2, 43.5, 41.8, 38.6, 32.6, 31.4, 26.0, 23.7, 22.5, 21.7, 18.3, −5.3; LRMS-ESI (+) m/z 673.3 [M + H]+.

1-Benzyl Fendleridine (32).25

To a Parr reactor vessel under Argon was added 2800 Ra-Ni (51 mg, 300 wt %). A solution of tosylate 26 (17 mg, 25 μmol, 1.0 equiv) in MeOH (1 mL, 27 mM) was then cannulated in the flask. The mixture was shaken in a Parr™ apparatus under hydrogen at 60 Psi pressure for 21 h. After this period, the resulting white solution mixture was filtered through Celite® and filter-cake was washed with MeOH and CH2Cl2 (10 mL each). Solvents were evaporated and the crude material (31) was used directly for the next reaction. LRMS-ESI (+) m/z 501.3 [M]+.

To a flame-dried flask under Argon equipped with a stir bar, above crude product (31) was dissolved in freshly distilled THF (0.3 mL, 0.1 M) and TBAF (1 M in THF, 30 μL, 0.03 mmol, 1.2 equiv) was added and the resulting reaction mixture was stirred for 12 h. Reaction was then quenched with H2O (~.5 mL), extracted with EtOAc (3x), washed with brine, dried with Na2SO4, and concentrated. The crude mixture was purified via column chromatography over silica gel using 70% -80% EtOAc:Hexanes as the eluent to provide benzyl derivative 32 (5.9 mg, 62% yield over 2 steps) as an off-white amorphous solid. TLC: Alumina (5% EtOAc:Hexanes), Rf = 0.50. [α]D20 +3.0 (c 0.155, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.36 (dd, J = 7.4, 1.3 Hz, 1H), 7.29 – 7.15 (m, 5H), 6.94 (td, J = 7.6, 1.3 Hz, 1H), 6.59 (td, J = 7.4, 1.1 Hz, 1H), 6.27 (dd, J = 7.8, 1.0 Hz, 1H), 4.34 (d, J = 15.4 Hz, 1H), 4.06 (d, J = 15.4 Hz, 1H), 3.89 – 3.75 (m, 2H), 3.22 (dd, J = 7.6, 4.1 Hz, 1H), 2.91 – 2.82 (m, 2H), 2.74 – 2.64 (m, 1H), 2.59 – 2.51 (m, 1H), 2.14 (ddd, J = 13.2, 8.9, 6.6 Hz, 1H), 1.98 – 1.84 (m, 2H), 1.77 (dd, J = 21.1, 10.6 Hz, 1H), 1.64 – 1.50 (m, 3H), 1.50 – 1.38 (m, 3H), 1.29 – 1.19 (m, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 151.2, 139.0, 135.0, 128.6, 127.7, 127.5, 127.1, 125.9, 117.9, 106.5, 101.9, 71.5, 64.9, 57.9, 49.6, 49.2, 44.1, 38.6, 38.3, 36.9, 34.7, 27.4, 21.64, 21.56; HRMS-ESI (+) m/z calcd for C26H31N2O [M + H]+: 387.2431, found 387.2429.

(+)-Fendleridine (2).25,27a

A flame-dried round bottom flask under Argon was equipped with a stir bar and cold-finger condenser with dry ice and acetone. NH3 was allowed to condense into the flask (1 mL) and the cold finger condenser was removed and a septum with an Argon balloon quickly replaced it. To this, small chunks of freshly cut Li (30 mg, 167 equiv) washed with hexanes were added. The solution turned dark blue. Benzyl derivative 32 (10 mg, 0.03 mmol, 1 equiv) in a mixture (10:1) of THF and t-BuOH (0.5 mL) was added and the reaction was allowed to stir for 2 h. Reaction was quenched with solid NH4Cl (~100 mg, 72.3 eq) and cooling bath was removed and the reaction was warmed to 23 °C. Reaction diluted with EtOAc (1 mL), filtered through cotton plug with CH2Cl2and EtOAc (5 mL each), and concentrated. The crude mixture was purified via column chromatography over alumina using 5% EtOAc:Hexanes as the eluent to provide synthetic (+)fendleridine, (+)-2 as off-white amorphous solid (5.3 mg, 70%). TLC: Alumina (5% EtOAc:Hexanes), Rf = 0.13. [α]D20 +53.7 (c 0.177, CHCl3); 1H NMR (800 MHz, CDCl3) δ 7.45 (d, J = 7.5 Hz, 1H), 7.01 (t, J = 7.6 Hz, 1H), 6.73 (t, J = 7.5 Hz, 1H), 6.60 (d, J = 7.7 Hz, 1H), 4.03 – 3.95 (m, 2H), 3.52 (bs, 1H), 3.40 (dd, J = 9.5, 4.8 Hz, 1H), 3.00 (td, J = 8.7, 4.1 Hz, 1H), 2.92 (dt, J = 15.6, Hz, 1H), 2.79 (t, J = 11.4 Hz, 1H), 2.65 (d, J = 11.1 Hz, 1H), 2.24 (ddd, J = 13.4 8.7, 5.9 Hz, 1H), 1.92 – 1.83 (m, 2H), 1.81 (td, J = 12.9, 4.0 Hz, 1H), 1.78 – 1.71 (m, 2H), 1.71 – 1.59 (m, 2H), 1.51 (dt, J = 12.1, 3.2 Hz, 1H), 1.45 (dt, J = 13.8, 4.8 Hz, 1H), 1.35 (d, J = 13.0 Hz, 1H), 1.24 (dd, J = 11.9, 5.5 Hz, 1H); 13C{1H} NMR (201 MHz, CDCl3) δ 150.3, 134.4, 127.3, 126.1, 119.4, 110.0, 102.1, 66.6, 64.9, 58.9, 49.3, 44.1, 39.2, 37.0, 35.8, 34.1, 27.3, 27.0, 21.5; HRMS-ESI (+) m/z calcd for C19H25N2O [M + H]+: 297.1961, found 297.1964.

(+) – Acetylaspidoalbidine (3).25,27a

To a flame-dried round bottom flask under Argon equipped with a stir bar, synthetic fendleridine (7.9 mg, 0.027 mmol, 1.0 equiv) was dissolved in CH2Cl2 (1 mL), was added. Pyridine (11 μL, 0.13 mmol, 5.0 equiv) and acetic anhydride (7.5 μL, 0.08 mmol, 3.0 equiv) were added sequentially. Reaction was quenched with saturated NaHCO3 (~ 0.1 mL), extracted 3x with CH2Cl2, dried Na2SO4, and concentrated. The crude mixture was purified via column chromatography using 15 – 20% EtOAc:Hexanes as the eluent to provide products (+)-3 (rotamers) as white amorphous solid (9 mg, quantitative yield). TLC: Alumina (5% EtOAc:Hexanes), Rf = 0.08. [α]D20 +30.2 (c 0.145, CHCl3); 1H NMR (800 MHz, CDCl3) δ 8.14 (d, J = 8.0 Hz, 1H), 7.67 (d, J = 3.5 Hz, 0.3H) 7.60 (d, J = 7.7 Hz, 1H, minor rotamer), 7.19 (t, J = 7.7 Hz, 1H), 7.05 (t, J = 7.5 Hz, 1H), 4.42 (dd, J = 9.12, 4.16 Hz, minor rotamer), 4.16 (t, J = 8.6 Hz, 1H), 4.09 (dt, J = 10.5, 7.5 Hz, 1H), 3.86 (dd, J = 11.0, 5.2 Hz, 1H), 3.02 (td, J = 8.8, 4.1 Hz, 1H), 2.93 (dd, J = 15.7, 9.0 Hz, 1H), 2.80 (td, J = 11.5, 2.8 Hz, 1H), 2.65 (d, J = 10.7 Hz, 1H), 2.39 (s, 0.6H, minor rotamer), 2.26 (s, 2.1H), 2.10 (ddd, J = 14.6, 9.1, 6.1 Hz, 1H), 2.07 – 2.00 (m, 1H), 1.93 (m, 1H), 1.86 (m, 1H), 1.83 – 1.66 (m, 4H), 1.55 (dt, J = 12.7, 3.6 Hz, 0.8H), 1.50 (t, J = 13.9Hz, .2 H, minor rotamer), 1.43 (dt, J = 14.0, 3.9 Hz, 1H), 1.38 (d, J = 12.9 Hz, 1H), 1.27 (m, 1H); 13C{1H} NMR (201 MHz, CDCl3, major rotamer) δ 168.2, 141.2, 137.9, 127.5, 124.9, 124.8, 117.9, 102.2, 69.0, 65.1, 58.4, 49.1, 44.1, 39.8, 37.3, 34.9, 33.2, 26.6, 25.5, 23.5, 21.2; 13C{1H} NMR (201 MHz, CDCl3, minor rotamer) δ 168.0, 140.6, 140.1, 127.1, 126.1, 124.3, 115.1, 102.5, 67.1, 65.0, 57.2, 48.9, 43.9, 39.6, 37.0, 35.2, 33.5, 26.8, 24.4, 23.8, 21.2; HRMS-ESI (+) m/z calcd for C21H27N2O2 [M + H]+: 339.2067, found 339.2064.

Supplementary Material

Supporting Information

ACKNOWLEDGEMENTS

Financial support of this work was provided by the National Institutes of Health (GM122279) and Purdue University.

Footnotes

Conflicts of interest

There are no conflicts to declare.

ASSOCIATED CONTENT

Supporting Information

Full spectroscopic data for all compounds are available free of charge via the Internet at http://pubs.acs.org

REFERENCES

  • (1).(a)Lopchuk JM In Progress in Heterocyclic Chemistry; Gribble GW, Joule JA, Eds.; Elsevier, 2011; Vol. 23, pp 1–25. [Google Scholar]; (b)O’Connor SE 1.25 -Alkaloids In Comprehensive Natural Products II; Liu H.-W.(Ben), Mander L, Eds.; Elsevier: Oxford, 2010; pp 977–1007. [Google Scholar]
  • (2).(a)Saxton JE In The Alkaloids: Chemistry and Biology; Cordell GA, Ed.; Academic Press, 1998; Vol. 50, pp 343–376. [Google Scholar]; (b)Saxton JE In The Alkaloids: Chemistry and Biology; Cordell GA, Ed.; Academic Press, 1998; Vol. 51, pp 1–197. [Google Scholar]
  • (3).Blair LM; Calvert MB; Gaich T; Lindel T; Phaffenbach M; Sperry J In The Alkaloids: Chemistry and Biology; Knölker H-J, Ed.; Academic Press: New York, 2017; Vol. 77 pp 1–84.28212700 [Google Scholar]
  • (4).O’Connor SE; Maresh J Chemistry and biology of monoterpene indole alkaloid biosynthesis. J. Nat. Prod. Rep. 2006, 23, 532–547. [DOI] [PubMed] [Google Scholar]
  • (5).(a)Lobert S; Vulevic B; Correia JJ Interaction of Vinca Alkaloids with Tubulin:  A Comparison of Vinblastine, Vincristine, and Vinorelbine. Biochemistry, 1996, 35, 6806–6814. [DOI] [PubMed] [Google Scholar]; (b)Prakash V; Timasheff SN Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline. Biochemistry, 1991, 30, 873–880. [DOI] [PubMed] [Google Scholar]; (c)Safa AR; Hamel E; Felsted RL Photoaffinity labeling of tubulin subunits with a photoactive analog of vinblastine. Biochemistry, 1987, 26, 97–102. [DOI] [PubMed] [Google Scholar]
  • (6).Tanaka JCA; da Silva CC, de Oliveira AJB, Nakamura CV, Dias Filho BP Antibacterial activity of indole alkaloids from Aspidosperma ramiflorum. Brazilian Journal of Medicine and Biological Research, 2006, 39, 387–391. [DOI] [PubMed] [Google Scholar]
  • (7).Aquino PGV; de Aquino TM; Alexandre-Moreira MS; de Oliveira Santos BV; Santana AEG; de Araujo-Junior JX Aspidosperma Terpenoid Alkaloids -Biosynthetic Origin, Chemical Synthesis and Importance. Phytochemicals -Isolation, Characterisation and Role in Human Health, 2015, DOI: 10.5772/59758 [DOI] [Google Scholar]
  • (8).For pioneering earlier studies, see the following references (a) Stork G; Dolfini J The Total Synthesis of dl-Aspidospermine and of dl-Quebrachamine. J. Am. Chem. Soc. 1963, 85, 2872–2873. [Google Scholar]; (b)Harley-Mason J; Kaplan M A simple total synthesis of (±)-aspidospermidine. J. Chem. Soc., Chem. Commun. 1967, 915–916. [Google Scholar]; (c)Büchi G; Matsumoto KE; Nishimura H Total synthesis of (+-)-vindorosine. J. Am. Chem. Soc. 1971, 93, 3299–3301. [DOI] [PubMed] [Google Scholar]; (d)Kuehne ME; Roland DM; Hafter R Studies in biomimetic alkaloid syntheses. 2. Synthesis of vincadifformine from tetrahydro-.beta.-carboline through a secodine intermediate. J. Org. Chem. 1978, 43, 3705–3710. [Google Scholar]; (e)Andriamialisoa RZ; Langlois N; Langlois J A new efficient total synthesis of vindorosine and vindoline. J. Org. Chem. 1985, 50, 961–967. [Google Scholar]; (f)Cardwell K; Hewitt B; Ladlow M; Magnus P Methods for indole alkaloid synthesis. A study of the compatibility of the indole-2,3-quinodimethane strategy for the synthesis of 16-methoxy-substituted aspidosperma-type alkaloids. Synthesis of (+)-and (−)-16-methoxytabersonine. J. Am. Chem. Soc. 1988, 110, 2242–2248. [Google Scholar]; (g)Kozmin SA; Iwama T; Huang Y; Rawal VH An Efficient Approach to Aspidosperma Alkaloids via [4+2] Cycloadditions of Aminosiloxydienes: Stereocontrolled Total Synthesis of (±)-Tabersonine. Gram-Scale Catalytic Asymmetric Syntheses of (+)-Tabersonine and (+)-16-Methoxytabersonine. Asymmetric Syntheses of (+)-Aspidospermidine and (−)-Quebrachamine. J. Am. Chem. Soc. 2002, 124, 4628–4641. [DOI] [PubMed] [Google Scholar]
  • (9).(a)Zhao S; Andrade RB Domino Michael/Mannich/N-Alkylation Route to the Tetrahydrocarbazole Framework of Aspidosperma Alkaloids: Concise Total Syntheses of (−)-Aspidospermidine, (−)-Tabersonine, and (−)-Vincadifformine. J. Am. Chem. Soc. 2013, 135, 13334–13337. [DOI] [PubMed] [Google Scholar]; (b)Liu Y; Liniger M; McFadden RM; Roizen JL; Malette J; Reeves CM; Behenna DC; Seto M; Kim J; Mohr JT; Virgil SC; Stoltz BM Formal total syntheses of classic natural product target molecules via palladium-catalyzed enantioselective alkylation. Belstein J. Org. Chem. 2014, 10, 2501–2512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).(a)Horinouchi R; Kamei K; Watanabe R; Hieda N; Tatsumi N; Nakano K; Ichikawa Y; Kotsuki H Enantioselective Synthesis of Quaternary Carbon Stereogenic Centers through the Primary Amine‐Catalyzed Michael Addition Reaction of α‐Substituted Cyclic Ketones at High Pressure. Eur. J. Org. Chem. 2015, 4457–4463. [Google Scholar]; (b)Mori M; Nakanishi M; Kajishima D; Sato Y A Novel and General Synthetic Pathway to Strychnos Indole Alkaloids:  Total Syntheses of (−)-Tubifoline, (−)-Dehydrotubifoline, and (−)-Strychnine Using Palladium-Catalyzed Asymmetric Allylic Substitution. J. Am. Chem. Soc. 2003, 125, 9801–9807. [DOI] [PubMed] [Google Scholar]
  • (11).(a)Cava MP; Talapatra SK; Nomura K; Weisbach JA; Douglas B; Shoop EC Haplocine and Haplocidine: Aspidospermine-Type Alkaloids from Haplophyton cimicidum. Chem. and Ind. 1963, 1242–1243. [Google Scholar]; (b)Cava MP; Nomura K; Talapatra SK The stereochemistry of limaspermine, haplocine and haplocidine. Tetrahedron 1964, 20, 581–583. [Google Scholar]
  • (12).Hart MJ; Glicksman M; Liu M; Sharma MK; Cuny G; Galvan V Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein. Anal. Biochem. 2012, 421, 467–476. [DOI] [PubMed] [Google Scholar]
  • (13).(a)Cava MP; Talapatra SK; Yates P; Rosenberger M; Szano AG; Douglas B; Raffauf RF; Shoop EC; Weisbach JA Cimicine and Cimicidine: Lactonic Alkaloids of the Aspidospermine Skeletal Type. Chem. and Ind. 1963, 1875–1876. [Google Scholar]; (b)Cava MP; Lakshmikantham MV; Talapatra SK; Yates P; Rae D; Rosenberger M; Szabo AG; Douglas B; Weisbach JA Cimicine and Cimicidine, Lactonic Alkaloids from Haplophyton cimicidum. Can. J. Chem. 1973, 51, 3102–3109. [Google Scholar]
  • (14).Satoh H; Ueda H; Tokuyama H Divergent total synthesis of (−)-aspidophytine and its congeners via Fischer indole synthesis. Tetrahedron 2013, 69, 89–95. [Google Scholar]
  • (15).Burnell RH, Medina JD, and Ayer WA Alkaloids of the Seeds of Aspidosperma Fendleri WOODSON. Can. J. Chem. 1966, 44, 28–31. [Google Scholar]
  • (16).Medina JD and Genova LD Alkaloids of the Bark of Aspidosperma rhombeosignatum. Planta Med. 1979, 37, 165–167. [Google Scholar]
  • (17).(a)Brown KS, Budzikiewicz H, and Djerassi C Alkaloid studies XLII. The structures of dichotamine, 1-acetyl-aspidoalbidine and 1-acetyl-17-hydroxyaspidoalbidine: three new alkaloids from vallesiadichotoma ruiz et pav. Tetrahedron Lett. 1963, 4, 1731–1736. [Google Scholar]; (b)Walser A and Djerassi C Alkaloid-Studien LII. Die Alkaloide aus Vallesia dichotoma RUIZet PAV. Helv. Chim. Acta 1965, 48, 391–404. [Google Scholar]
  • (18).Tan SH; Banwell MG; Willis AC; Reekie TA Application of a Raney-Cobalt-Mediated Tandem Reductive Cyclization Protocol to Total Syntheses of the Aspidosperma Alkaloids (±)-Limaspermidine and (±)-1-Acetylaspidoalbidine. Org. Lett. 2012, 14, 5621–5623. [DOI] [PubMed] [Google Scholar]
  • (19).Ban Y; Ohnuma T; Seki K; Oishi T The total synthesis of the alkaloid (±)-1-acetylaspidoalbidine. Tetrahedron Lett. 1975, 16, 727–730. [Google Scholar]
  • (20).Jin J; Qiu FG Total Synthesis of (±)‐1‐Acetylaspidoalbidine and (±)‐1‐Methylaspidospermidine. Adv. Synth. Catal. 2014, 356, 340–346. [Google Scholar]
  • (21).(a)Honma Y; Ohnuma T; Ban Y A Total Synthesis of (±)-Fendleridine. Heterocycles 1976, 5, 47–51. [Google Scholar]; (b)Yoshido K; Sakuma Y; Ban Y Synthetic Studies on Oxygenated Aspidoserma Alkaloids: Facile Syntheses of 1-Acetylaspidoalbidine and Deoxyaspidodispermine. Heterocycles 1987, 25, 47–50. [Google Scholar]
  • (22).Overman LE; Sworin M; Burk RM Synthesis applications of aza-Cope rearrangements. Part 10. A new approach for the total synthesis of pentacyclic Aspidosperma alkaloids. Total synthesis of dl-16-methoxytabersonine. J. Org. Chem. 1983, 48, 2685–2690. [Google Scholar]
  • (23).For the total synthesis of the related alkaloid aspidophytine, see: (a) He F; Bo Y; Altom JD; Corey EJ Enantioselective Total Synthesis of Aspidophytine. J. Am. Chem. Soc. 1999, 121, 6771–6772. [Google Scholar]; (b)Sumi S; Matsumoto K; Tokuyama H; Fukuyama T Stereocontrolled total synthesis of (−)-aspidophytine. Tetrahedron 2003, 59, 8571–8587. [Google Scholar]; (c)Mejia-Oneto JM; Padwa A Application of the Rh(II) Cyclization/Cycloaddition Cascade for the Total Synthesis of (±)-Aspidophytine. Org. Lett. 2006, 8, 3275–3278. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d)Marino JP; Cao G Total synthesis of aspidophytine. Tetrahedron Lett. 2006, 47, 7711–7713. [Google Scholar]; (e)Nicolaou KC; Dalby SM; Majumder U A Concise Asymmetric Total Synthesis of Aspidophytine. J. Am. Chem. Soc. 2008, 130, 14942–14943. [DOI] [PubMed] [Google Scholar]
  • (24).Doris E Total syntheses of (+)-haplophytine. Angew. Chem. Int. Ed. 2009, 48, 7480–7483. [DOI] [PubMed] [Google Scholar]
  • (25).Campbell EL; Zuhl AM; Liu CM; Boger DL Total Synthesis of (+)-Fendleridine (Aspidoalbidine) and (+)-1-Acetylaspidoalbidine. J. Am. Chem. Soc. 2010, 132, 3009–3012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (26).Wilkie GD; Elliott GI; Blagg BSJ; Wolkenberg SE; Soenen DR; Miller MM; Pollack S; Boger DL Intramolecular Diels−Alder and Tandem Intramolecular Diels−Alder/1,3-Dipolar Cycloaddition Reactions of 1,3,4-Oxadiazoles. J. Am. Chem. Soc. 2002, 124, 11292–11294. [DOI] [PubMed] [Google Scholar]
  • (27).(a)White KL; Movassaghi MC Concise Total Syntheses of (+)-Haplocidine and (+)-Haplocine via Late-Stage Oxidation of (+)-Fendleridine Derivatives. J. Am. Chem. Soc. 2016, 138, 11383–11389. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b)Mewald M; Medley JW; Movassaghi M Concise and enantioselective total synthesis of (−)-mehranine, (−)-methylenebismehranine, and related Aspidosperma alkaloids. Angew. Chem., Int. Ed. 2014, 53, 11634–11639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (28).(a)Dugat D; Gramain J-C; Dauphin G Structure, stereochemistry, and conformation of diastereoisomeric cis-and trans-3-ethyl-1,2,3,4,4a,9a-hexahydrocarbazol-4-ones by means of 13C and two-dimensional 1H nuclear magnetic resonance spectroscopy. An example of diastereoselection in a photocyclisation reaction. J. Chem. Soc. Perkin Trans. 2 1990, 605–611. [Google Scholar]; (b)Gramain J-C; Troin Y; Husson H-P A short and efficient synthesis of 4a‐substituted cis‐hexahydro‐1,2,3,4,4a,9a‐carbazol‐4‐ones. J. Heterocycl. Chem. 1988, 25, 201–203. [Google Scholar]; (c)Gramain J-C; Husson HP; Troin Y A novel and efficient synthesis of the aspidosperma alkaloid ring system: N(a)-benzyldeethylaspidospermidine. J. Org. Chem. 1985, 50, 5517–5520. [Google Scholar]
  • (29).(a)McFadden RM; Stoltz BM The Catalytic Enantioselective, Protecting Group-Free Total Synthesis of (+)-Dichroanone. J. Am. Chem. Soc. 2006, 128, 7738–7739. [DOI] [PubMed] [Google Scholar]; (b)Behenna DC Mohr JT; Sherden NH; Marinescu SC; Harned AM; Tani K; Seto M; Ma S; Novák Z; Krout MR; McFadden RM; Roisen JL; Enquist JA Jr.; White DE; Leine SR; Petrova KV; Iwashita A; Virgil SC; Stoltz BM Enantioselective Decarboxylative Alkylation Reactions: Catalyst Development, Substrate Scope, and Mechanistic Studies. Chem. -Eur. J. 2011, 17, 14199–14223. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c)Mohr JT; Stoltz BM Enantioselective Tsuji Allylations. Chem. -Asian J. 2007, 2, 1476–1491. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d)Bennet NB; Duquette DC; Kim J; Liu W; Marziale AN; Behenne DC; Virgil SC; Stoltz BM Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation of N-Heterocyclic Molecules and Cyclic Ketones. Chem. -Eur. J. 2013, 19, 4414 – 4418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (30).Zhao X; Li W; Wang J; Ma D Convergent Route to ent-Kaurane Diterpenoids: Total Synthesis of Lungshengenin D and 1α,6α-Diacetoxy-ent-kaura-9(11),16-dien-12,15-dione. J. Am. Chem. Soc. 2017, 139, 2932–2935. [DOI] [PubMed] [Google Scholar]
  • (31).Bennett NB; Duquette DC; Kim J; Liu W; Marziale AN; Behenna DC; Virgil SC; Stoltz BM Expanding Insight into Asymmetric Palladium-Catalyzed Allylic Alkylation of N-Heterocyclic Molecules and Cyclic Ketones. Chem. Eur. J. 2013, 19, 4414–4418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (32).Weaver JD; Recio A; Grenning AJ; Tunge JA Transition Metal-Catalyzed Decarboxylative Allylation and Benzylation Reactions. Chem. Rev. 2011, 111, 1846–1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (33).Modha SG; Pöthig A; Dreuw A; Bach T [6π] Photocyclization to cis Hexahydrocarbazol-4-ones: Substrate Modification, Mechanism, and Scope. J. Org. Chem. 2019, 84, 1139–1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (34).(a)Brown HC; Prasad JVNV; Zee SH Hydroboration. 71. Hydroboration of representative heterocyclic olefins with borane-methyl sulfide, 9-borabicyclo[3.3.1]nonane, dicyclohexylborane, and disiamylborane. Synthesis of heterocyclic alcohols. J. Org. Chem. 1985, 50, 1582–1589. [Google Scholar]; (b)Brown HC; Prasad JVNV; Zee SH Hydroboration. 75. Directive effects in the hydroboration of vinyl and propenyl heterocycles with representative hydroborating agents. J. Org. Chem. 1986, 51, 439–445. [Google Scholar]
  • (35).Schultz AG; Dittami SOM; Sha CK; A New 2-Azatricyclo[4.4.0.02,8]decenone Synthesis and Ketene Formation by Retro-Diels-Alder Reaction. J. Am. Chem. Soc. 1983, 105, 3273–3279. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES